secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2025-02-21T23:59:59+00:00
Accession:  0001193125-25-032092
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose Biosciences announces 1-for-30 reverse stock split effective Feb 26, 2025
--------------------------------------------------------------------------------

- Reverse stock split ratio set at 1-for-30; trading on split-adjusted basis begins Feb 26.
- Post-split shares outstanding approx. 2.1M; no fractional shares issued; rounded down to whole share.
- CUSIP changes to 03835T408 and ISIN to CA03835T4081 effective Feb 26.
- Proportionate adjustments to outstanding equity awards, exercise prices, and equity incentive plans.
- Shares continue trading on Nasdaq (APTO) and TSX (APS).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000119312525032092/0001193125-25-032092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000119312525032092/d934231d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-032092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer